In particular, a combination of methylation markers ZNF582 and ASCL1 shows the highest accuracy for AIN3+ detection and provides a promising tool to identify HSIL at risk of progression to cancer and in need of treatment [14, 15]. This evidence concerns the gene ZNF582 and cancer.